HAVN Life Sciences Inc.

HAVN Life Sciences Inc.

HAVN Life Enters into Definitive Agreement to Acquire Spore Life Sciences Inc.

The Subscription-based Functional Mushroom Company has established a significant consumer base in the U.S. VANCOUVER, BC, Dec. 20, 2021 - Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "Havn Life"), a biotechnology company developing natural health products and innovative therapies to support central nervous... Read More...

Mycotopia Therapies Signs Agreement With Havn Life Sciences For Purchase of Psilocybin SPP

Both companies to follow necessary protocols to allow for export of naturally-derived psilocybin from Canada and import into the USMIAMI, Aug. 25, 2021 -- Mycotopia Therapies, Inc. (OTC Pink: TPIA) (the “Company”), a company focused on psychedelic therapies, announced today it has entered into a Psilocybin Supply Agreement with Havn Life ... Read More...